Zu den Inhalten springen

Klinik für Innere Medizin IHämatologie, Onkologie und Stammzelltransplantation

Herausragende Publikationen

2017

The New England Journal of Medicine

Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy.

Zeiser R, Blazar BR. | N Engl J Med. 2017 Nov 30;377(22):2167-2179.


Phosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesis.

Gerboth S, Frittoli E, Palamidessi A, Baltanas FC, Mogjiborahman S, Rappsilber J, Giuliani C, Troglio F, Rolland Y, Pruneri G, Kreutmair S, Pallavicini I, Zobel M, Cinquanta M, Minucci S, Gomez C, Santos E, Illert AL, Scita G.
Leukemia. 2017 Aug 18. doi: 10.1038/leu.2017.267.

www.ncbi.nlm.nih.gov/pubmed/28819285


Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trial

Jürgen Finke, Claudia Schmoor, Wolfgang Andreas Bethge, Hellmut Ottinger, Matthias Stelljes, Liisa Volin, Dominik Heim, Hartmut Bertz,Olga Grishina, Gerard Socie
Lancet Haematol
2017;4: e293–301
Full text

Comment | Frédéric Baron

Unrelated donor haemopoietic stem-cell transplantation: ATG or not?

Full text


High-throughput sequencing for noninvasive disease detection in hematologic malignancies

Florian Scherer, David M. Kurtz, Maximilian Diehn and Ash A. Alizadeh

Blood 2017 :blood-2017-03-735639; doi:

mehr

Combined mutation in Vhl, Trp53 and Rb1 causes clear cell renal cell carcinoma in mice.

Harlander S, Schönenberger D, Toussaint NC, Prummer M, Catalano A, Brandt L, Moch H, Wild PJ, Frew IJ.

Nature Medicine. 2017 May 29. doi: 10.1038/nm.4343. [Epub ahead of print]

mehr

MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT-signaling in dendritic cells after stem cell transplantation.

Stickel N, Hanke K, Marschner D, Prinz G, Köhler M, Melchinger W, Pfeifer D, Schmitt-Graeff A, Brummer T, Heine A, Brossart P, Wolf D, von Bubnoff N, Finke J, Duyster J, Ferrara J, Salzer U, Zeiser R. 

Leukemia (9 May 2017) | doi:10.1038/leu.2017.137

mehr

New Paper by Rouven Hoefflin et al.

  • Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity

    Rouven Hoefflin, Bernd Lahrmann, Gregor Warsow, Daniel Hübschmann, Cathleen Spath, Britta Walter, Xin Chen, Luisa Hofer, Stephan Macher-Goeppinger, Yanis Tolstov, Nina Korzeniewski, Anette Duensing, Carsten Grüllich, Dirk Jäger, Sven Perner, Gita Schönberg, Joanne Nyarangi-Dix, Sanjay Isaac, Gencay Hatiboglu, Dogu Teber et al.

    Nature Communications 7, Article number: ncomms11845doi:10.1038/ncomms11845 | Received 21 January 2016 | Accepted 04 May 2016 | Published 13 June 2016

    ==> http://www.nature.com/articles/ncomms11845

Cover image, Blood, April 14, 2016

Publikation AG Zeiser | April 14, 2016; Blood

About the Cover

Logo JEM

The Journal of Experimental Medicine

New Paper by PD Dr. Christine Dierks und Team:

Ptch2 loss drives myeloproliferation and myeloproliferative neoplasm progression.

Klein C, Zwick A, Kissel S, Forster CU, Pfeifer D, Follo M, Illert AL,Decker S, Benkler T, Pahl H, Oostendorp RA, Aumann K, Duyster J,Dierks C.

J Exp Med. 2016 Feb 8;213(2):273-90. doi: 10.1084/jem.20150556. Epub2016 Feb 1.

2015

Neues GvHD Behandlungs Konzept aus Freiburg

Prof. Zeiser/Prof. von Bubnoff

WOCHENPLAN
Wochenplan

Klinik für Innere Medizin I
KW 50

11.11.2017 - 17.12.2017

Klinik für Innere Medizin I

Klinik für Tumorbiologie

Hämatologie, Onkologie und
Stammzelltransplantation

Hugstetter Straße 55
79106 Freiburg